Precision Business Insights
Portfolio

 

Research Reports

Europe Poultry Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Europe Poultry Drugs Market: By Drug Type (Parasiticides, Antibiotics, Anti-inflammatory Drugs, and Others) By Animal Type (Turkey, Chicken, Goose, Duck, Others), and Geography – Europe Poultry Drugs Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Market Dynamics: Europe Poultry Drugs Market

 

Drugs are the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. Rise in the demand for healthy meat and eggs, increase in the R&D activities for the innovation of newer drugs, collaborations and acquisitions between the companies, increase in prevalence of various infectious diseases, and high awareness about the poultry diseases and drugs among veterinary professionals are expected to boost the Europe poultry drugs market. However, stringent regulatory policies for product approval, ban of antibiotics usage in poultry, high cost of R&D activities, and adverse effects associated with the drugs may restrain the growth of Europe poultry drugs market over the forecast timeframe.

 

Market Scope: Europe Poultry Drugs Market

Europe poultry drugs market is segmented on the basis of drug type, animal type, and country

Based on the drug type, the market is segmented into the following:

  • Parasiticides
  • Antibiotics
  • Anti-inflammatory Drugs
  • Others

Based on the animal type, the market is segmented into the following:

  • Turkey
  • Chicken
  • Goose
  • Duck
  • Others

Based on the country, the market is segmented into the following:

  • Germany
  • France
  • K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

 

Country Analysis:  Poultry Drugs Market

Geographically, Europe poultry drugs market is segmented into Germany, France, U.K, Italy Spain, Russia, Poland, and Rest of Europe. Germany poultry drugs market growth attributed to rise in demand for healthy meat, increase in the R&D activities for the innovation of newer drugs, rise in prevalence infectious diseases, and rise in per capita income. France poultry drugs market has a lucrative growth due to disease outbreak in poultry, innovation of newer drugs and vaccines by the companies, and adoption of newer drugs in the market. U.K. poultry drugs market is growing due to government support for the poultry production, increase in animal healthcare expenditure, and rise in funding from the government organiations for the development of newer drugs.

 

Competition Assessment: Europe Poultry Drugs Market

Some of the players in the Europe poultry drugs market include:

  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Virbac S.A. (France)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Phibro Animal health Corporation (U.S.)
  • Zydus AHL (India)
  • Ceva Sante Animale (France)

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies and regulatory framework
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Virbac S.A. (France)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Phibro Animal health Corporation (U.S.)
  • Zydus AHL (India)
  • Ceva Sante Animale (France)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 2,000.00$ 6,900.00
Region Europe
Clear selection

Select License Type

Databank Europe $ 2,000.00
spinner
Single User Europe $ 3,100.00
spinner
Multiple User Europe $ 4,600.00
spinner
Corporate UserEurope $ 6,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials